Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma.

ABSTRACT:

Importance

Neoadjuvant therapy (NT) is an increasingly used treatment strategy for patients with localized pancreatic ductal adenocarcinoma (PDAC). Little research has been conducted on cancer care delivery during NT, and the standards for optimal delivery of NT have not been defined.

Objective

To develop consensus best practices for delivering NT to patients with localized PDAC.

Design, setting, and participants

This study used a modified Delphi approach consisting of 2 rounds of voting, and a series of virtual conferences (from October to December 2023) to reach expert consensus on candidate best practice statements generated from a systematic review of the literature and expert opinion. An interdisciplinary panel was formed including 47 North American experts from

SUBMITTER: Cloyd JM 

PROVIDER: S-EPMC11618571 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature